| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PPP4R1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | ENC1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | ATP6V1B2 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | RGS1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | TNFRSF18 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | TLR7 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | CUX1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | IRF4 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | MC3R | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | SIGLEC7 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
